The
following shares were excluded from the calculation of weighted average dilutive common shares because their inclusion would have been
anti-dilutive:
SCHEDULE OF CALCULATION WEIGHTED AVERAGE DILUTIVE COMMON SHARES
| |
For the Three and Six Months Ended | |
| |
June 30, | |
| |
2025 | | |
2024 | |
Stock options (1) | |
| 96,828 | | |
| 97,919 | |
Warrants (2) | |
| 33,574 | | |
| 33,574 | |
| |
| 130,402 | | |
| 131,493 | |
(1) |
Represents
all outstanding stock options as of June 30, 2025. The weighted average exercise price for anti-dilutive options was $61.76 for the
three and six months ended June 30, 2025, respectively. |
(2) |
Represents
all outstanding warrants as of June 30, 2025, excluding the Pre-Funded Warrant. The exercise price for the warrants range from $21.74
to $29.38. |
|